Cartesian Therapeutics (RNAC) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-3.46
-2.14
-0.82
0.5

Details

Expected EPS
-0.869775
Actual EPS
N/A
Surprise EPS
0.87
Surprise Percent
+100%

Description

Cartesian Therapeutics (RNAC) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts